Schonfeld Strategic Advisors’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-596
Closed -$178K 2240
2021
Q1
$178K Sell
596
-591
-50% -$181K ﹤0.01% 1546
2020
Q4
$362K Buy
1,187
+287
+32% +$84.3K ﹤0.01% 1141
2020
Q3
$264K Buy
+900
New +$264K 0.01% 1132

Other funds holding RBOT

Schonfeld Strategic Advisors's RBOT Position: Q2 2021 in Review

Schonfeld Strategic Advisors sold out of Vicarious Surgical (RBOT) in Q2 2021, closing a stake of 596 shares — an estimated $178K sold.

Schonfeld Strategic Advisors first reported a position in RBOT in Q3 2020 and held it in 3 quarters. The position peaked at $362K in Q4 2020. 98 funds tracked by Wall St. Rank hold RBOT as of Q2 2021.

  • Schonfeld Strategic Advisors reported no remaining Vicarious Surgical position as of Q2 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 596 Vicarious Surgical shares in Q2 2021, an estimated $178K.
  • Schonfeld Strategic Advisors first reported a position in Vicarious Surgical in Q3 2020 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's Vicarious Surgical position peaked at $362K in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.